phrykt

Biovie Inc. (BIVI): who owns it and who trades it

As of Nov 16, 2026, BIVI insiders reported 5 purchases worth $52K in the last 12 months. The largest buyer was Cuong V Do (CEO), with $34.5K.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

In the last 12 months, BIVI insiders reported $52K of open-market purchases and $0 of sales.

Purchases, 12 months
$52K
5 trades, 4 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
Nov 13, 2026
Filed Nov 16, 2026

Purchases and sales by month

$49.1K$49.1KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 13, 2026Cuong V DoCEOPurchase2,500$1.16$2.9KForm 4
Aug 28, 2026Joseph M PalumboChief Medical OfficerPurchase4,843$2.16$10.5KForm 4
Aug 28, 2026Amy Suzon ChappellDirectorPurchase727$2.16$1.6KForm 4
Aug 28, 2026Joanne Wendy KimCFOPurchase2,500$2.18$5.5KForm 4
Aug 27, 2026Cuong V DoCEOPurchase15,210$2.08$31.6KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Cuong V DoPresident & CEO, Director$34.5K–Nov 13, 2026
Joseph M PalumboChief Medical Officer$10.5K–Aug 28, 2026
Joanne Wendy KimChief Financial Officer$5.5K–Aug 28, 2026
Amy Suzon ChappellDirector$1.6K–Aug 28, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

BIVI short interest

Moderate short interest. 7.8% of BIVI shares are sold short: about 1 share in 13. Over the last 12 reports the number of shares short went up 211%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 589,058 BIVI shares were sold short, 7.8% of the shares outstanding, up 8.2% from the report before. At the average daily volume of 160,191 shares, buying them all back would take about 3.7 trading days (days to cover).

Shares short, % of all shares

7.81%May 15Oct 3018.8%

Days to cover

3.7May 15Oct 305.0

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026589,0587.81%+8%160,1913.7
Oct 15, 2026544,4447.22%-35%196,9222.8
Sep 30, 2026831,29611.02%-21%304,9242.7
Sep 15, 20261.05M13.87%+18%438,2032.4
Aug 31, 2026884,69811.73%-29%11.80M1.0
Aug 14, 20261.25M16.63%+57%14.97M1.0
Jul 31, 2026800,58610.62%+22%180,4774.4
Jul 15, 2026655,2648.69%+46%255,8622.6
Jun 30, 2026449,0235.95%+50%223,4062.0
Jun 15, 2026300,2503.98%+59%121,4722.5
May 29, 2026188,4802.50%-0%92,4022.0
May 15, 2026189,3082.51%+7%117,8211.6

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Biovie company events

Biovie filed 4 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Nov 10, 2026.

  1. Nov 10, 2026VoteReported shareholder vote results. Filing
  2. Nov 6, 2026AgreementBioVie Inc. entered into a securities purchase agreement with an institutional investor, pursuant to which the Company agreed to issue and sell, in a registered direct offering, (i) 960,000 shares of the Company’s Class A common stock, par value $0.0001 per share, at an offering price of $1.60 per… Filing
  3. Sep 14, 2026AgreementBioVie Inc., a Nevada corporation, entered into a sales agreement with A.G.P./Alliance Global Partners, pursuant to which the Company may issue and sell from time to time, to or through the Agent, shares of the Company’s Class A common stock, par value $0.0001 per share, having an aggregate… Filing
  4. Aug 6, 2026AnnouncementShared information with investors. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Biovie financials

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named BIVI in the last 120 days.

FiledHolderFormStake
Nov 6, 2026JANE STREET GROUP, LLC13G/A2.7%
Nov 6, 2026JANE STREET GROUP, LLC13G/A2.7%

Questions about Biovie Inc. (BIVI) stock

Are BIVI insiders buying or selling?

In the last 12 months, BIVI insiders reported 5 open-market purchases worth $52K and no sales. The latest trade was on Nov 13, 2026. See every trade.

What is the short interest in BIVI?

As of Oct 30, 2026, 589,058 BIVI shares were sold short, 7.8% of the shares outstanding, up 8.2% from the report before. At the average daily volume of 160,191 shares, buying them all back would take about 3.7 trading days (days to cover). See the history.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.